LB Pharmaceuticals Inc (LBRX) Balance Sheet
As of 2026-06-30 (10-Q), LB Pharmaceuticals Inc (LBRX) reported total assets of $361.7M, total liabilities of $29.3M and shareholders' equity of $332.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $283.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LBRXLB Pharmaceuticals IncFollow LBRX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|
| Cash and equivalents | 250.2 | 283.1 | |
| Short-term investments | 45.0 | 44.7 | |
| Current assets | 308.4 | 355.3 | |
| Total assets | 312.9 | 361.7 | |
| Current liabilities | 7.4 | 23.6 | |
| Total liabilities | 11.6 | 29.3 | |
| Shareholders' equity | 301.3 | 332.3 |
USD millions · SEC XBRL
LB Pharmaceuticals Inc — questions
- How much cash does LB Pharmaceuticals Inc have?
- $283.1M in cash and cash equivalents as of 2026-06-30.
- What are LB Pharmaceuticals Inc's total assets?
- $361.7M as of 2026-06-30.
- What is LB Pharmaceuticals Inc's shareholders' equity?
- $332.3M as of 2026-06-30.
Every figure on this page comes from LB Pharmaceuticals Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.